Sweet Syndrome: Clinical Trials

2 trials for Sweet Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Sweet Syndrome: new trials by email Literature Review of Sweet Syndrome trials Research Report on Sweet Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery
Liposomal bupivacaine, Bupivacaine Hydrochloride - Pain Syndrome, Dizziness
Not applicableCompletedZhejiang Cancer Hospital1322024-12-032026-10-15
Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Collection of biological samples - Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue, Pyoderma Gangrenosum
UnknownUniversity of Zurich6002014-01-012016-09-27

Narrower conditions

Acute Generalized Exanthematous Pustulosis (1)  ·  Arthritis, Juvenile (1)  ·  Behcet Syndrome (1)  ·  Common Cold (1)  ·  Dermatitis Herpetiformis (1)  ·  Dizziness (1)  ·  Erythema elevatum diutinum (1)  ·  Hidradenitis (1)  ·  Keratosis (1)  ·  Linear IgA Bullous Dermatosis (1)  ·  Patient Satisfaction (1)  ·  Pruritus (1)  ·  Pyoderma Gangrenosum (1)  ·  Skin Diseases, Vesiculobullous (1)

Broader conditions

Erythema (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Behavior (1)  ·  Cardiovascular Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Dermatitis (1)  ·  Drug Eruptions (1)  ·  Drug Hypersensitivity (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Eye Diseases (1)

Interventions

Bupivacaine (1)

Sponsors

University of Zurich (1)  ·  Zhejiang Cancer Hospital (1)

Countries

China (1)  ·  Switzerland (1)

Top investigators

Alexander Navarini, MD (1)  ·  Jiangling Wang, Ph.D (1)